In recent trading session, Mustang Bio Inc (NASDAQ:MBIO) saw 16.92 million shares changing hands at last check today with its beta currently measuring 2.16. Company’s recent per share price level of $1.21 trading at -$0.12 or -8.98% at last check today assigns it a market valuation of $4.00M. That most recent trading price of MBIO’s stock is at a discount of -5271.9% from its 52-week high price of $65.00 and is indicating a premium of 6.61% from its 52-week low price of $1.13. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 69080.0 shares which gives us an average trading volume of 195.31K if we extend that period to 3-months.
For Mustang Bio Inc (MBIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Mustang Bio Inc (NASDAQ:MBIO) trade information
Upright in the red during last session for losing -8.98%, in the last five days MBIO remained trading in the red while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $1.21 price level, adding 12.34% to its value on the day. Mustang Bio Inc’s shares saw a change of -86.33% in year-to-date performance and have moved -9.70% in past 5-day. Mustang Bio Inc (NASDAQ:MBIO) showed a performance of -14.79% in past 30-days. Number of shares sold short was 60389.0 shares which calculate 0.63 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 51.52% during past 5 years.
Mustang Bio Inc (NASDAQ:MBIO)’s Major holders
Insiders are in possession of 12.67% of company’s total shares while institution are holding 3.77 percent of that, with stock having share float percentage of 4.32%. Investors also watch the number of corporate investors in a company very closely, which is 3.77% institutions for Mustang Bio Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 3.62 shares of worth $4396.0 or 0.15% of the total outstanding shares. The later fund manager was in possession of 1.47 shares on Dec 31, 2024 , making its stake of worth around $1784.0 in the company or a holder of 0.06% of company’s stock.
